Safety concerns with salmeterol

Green Vehicle Routing Problem with Safety and Social Concerns

Over the two last decades, distribution companies have been aware of the importance of paying attention to the all aspects of a distribution system simultaneously to be successful in the global market. These aspects are the economic, the environmental, the social and the safety aspects. In the Vehicle Routing Problem (VRP) literature, the economic issue has often been used, while the environmen...

Cardiovascular safety of salmeterol in COPD.

BACKGROUND Patients with COPD have an increased risk of cardiovascular disease. Despite the clinical benefits of long-acting beta-agonist agents in the treatment of COPD, patients may be at an increased risk of cardiovascular toxicity, including tachyarrhythmia due to beta-adrenergic stimulation. OBJECTIVE To evaluate the cardiovascular safety of salmeterol in COPD patients by conducting a po...

Drug safety and salmeterol: the controversy continues.

Since their introduction in the 1960s, inhaled -agonists have been celebrated for their ability to offer dramatic relief of symptoms for persons with asthma. However, they have engendered considerable controversy. Early indications suggested that higher doses of some of the shortacting -agonists were associated with higher fatal and near-fatal asthma-related events (1). Further research suggest...

Topical immunotherapy with dinitro-chlorobenzene: safety concerns.

Nanotechnology safety concerns revisited.

Nanotechnology is an emerging science involving manipulation of matter at the nanometer scale. Due to concerns over nanomaterial risks, there has been a dramatic increase in focused safety research. The present review provides a summary of these published findings, identifying areas of agreement and discordance with regard to: (1) the potential for nanomaterial exposure, (2) the relative hazard...